A video captures T cells learning to recognize cells from the body that shouldn’t be attacked.

The Mount Sinai oncologist studies innate immune cells with the goal of designing novel immunotherapies, including cancer vaccines.

A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.

Using single-cell RNA sequencing, scientists characterize new populations of dendritic cells and monocytes.

Research shows that human immunity develops much earlier than previously thought, but functions differently in adults.

Researchers document the diverse roles of immune cells in neuronal health and disease.

A dendritic cell vaccine targeting melanoma patients’ tumor-specific mutations can activate a broad range of cancer-fighting T cells. 

Vaccination via tiny microneedles elicits a powerful immune response in the skin.